BSE Live
Feb 04, 16:01Prev. Close
369.15
Open Price
370.20
Bid Price (Qty.)
356.00 (7)
Offer Price (Qty.)
356.00 (43)
NSE Live
Feb 04, 15:51Prev. Close
368.40
Open Price
366.85
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
355.95 (46)
| Key Financial Ratios of Medicamen Biotech (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 10.09 | 10.28 | 9.03 | 4.95 | 0.48 | |
| Diluted EPS (Rs.) | 10.09 | 10.28 | 9.03 | 4.95 | 0.48 | |
| Cash EPS (Rs.) | 12.08 | 12.17 | 10.40 | 6.73 | 2.38 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 100.25 | 74.05 | 63.77 | 25.46 | 17.92 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 100.25 | 74.05 | 63.77 | 25.46 | 17.92 | |
| Dividend / Share(Rs.) | 0.50 | 1.00 | 1.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 96.05 | 104.79 | 95.31 | 78.39 | 67.32 | |
| PBDIT/Share (Rs.) | 16.10 | 17.67 | 15.70 | 10.76 | 5.71 | |
| PBIT/Share (Rs.) | 14.06 | 15.78 | 13.94 | 8.93 | 3.82 | |
| PBT/Share (Rs.) | 13.59 | 14.98 | 11.88 | 6.05 | 0.71 | |
| Net Profit/Share (Rs.) | 10.03 | 10.28 | 8.64 | 4.91 | 0.48 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 16.76 | 16.86 | 16.47 | 13.72 | 8.48 | |
| PBIT Margin (%) | 14.63 | 15.05 | 14.62 | 11.38 | 5.66 | |
| PBT Margin (%) | 14.14 | 14.29 | 12.46 | 7.71 | 1.05 | |
| Net Profit Margin (%) | 10.44 | 9.80 | 9.06 | 6.25 | 0.71 | |
| Return on Networth / Equity (%) | 10.00 | 13.88 | 13.55 | 19.26 | 2.68 | |
| Return on Capital Employed (%) | 13.62 | 20.96 | 21.36 | 30.55 | 2.11 | |
| Return on Assets (%) | 6.94 | 8.80 | 8.60 | 7.03 | 0.80 | |
| Total Debt/Equity (X) | 0.08 | 0.13 | 0.19 | 0.62 | 1.02 | |
| Asset Turnover Ratio (%) | 66.49 | 89.75 | 94.85 | 112.33 | 112.09 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.93 | 1.98 | 2.21 | 1.25 | 1.09 | |
| Quick Ratio (X) | 1.59 | 1.67 | 1.86 | 0.93 | 0.79 | |
| Inventory Turnover Ratio (X) | 6.92 | 8.03 | 7.83 | 5.98 | 6.04 | |
| Dividend Payout Ratio (NP) (%) | 11.99 | 0.00 | 13.17 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 9.96 | 0.00 | 10.94 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 88.01 | 0.00 | 86.83 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 90.04 | 0.00 | 89.06 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 228.50 | 570.45 | 688.87 | 559.97 | 71.07 | |
| EV/Net Operating Revenue (X) | 1.95 | 4.65 | 6.18 | 6.79 | 1.06 | |
| EV/EBITDA (X) | 11.62 | 27.59 | 37.51 | 49.50 | 12.45 | |
| MarketCap/Net Operating Revenue (X) | 1.88 | 4.63 | 6.25 | 6.63 | 0.83 | |
| Retention Ratios (%) | 88.00 | 0.00 | 86.82 | 0.00 | 0.00 | |
| Price/BV (X) | 1.80 | 6.55 | 9.34 | 20.40 | 3.10 | |
| Price/Net Operating Revenue | 1.88 | 4.63 | 6.25 | 6.63 | 0.83 | |
| Earnings Yield | 0.06 | 0.02 | 0.01 | 0.01 | 0.01 |
26.11.2025
Medicamen Bio Consolidated September 2025 Net Sales at Rs 47.17 crore, up 5.42% Y-o-Y
24.11.2025
Medicamen Bio Standalone September 2025 Net Sales at Rs 42.23 crore, down 1.44% Y-o-Y
09.09.2025
Medicamen Bio Standalone June 2025 Net Sales at Rs 38.45 crore, down 7.31% Y-o-Y
11.06.2025
Medicamen Bio Standalone March 2025 Net Sales at Rs 26.00 crore, down 42.24% Y-o-Y
26.11.2025
Medicamen Bio Consolidated September 2025 Net Sales at Rs 47.17 crore, up 5.42% Y-o-Y
24.11.2025
Medicamen Bio Standalone September 2025 Net Sales at Rs 42.23 crore, down 1.44% Y-o-Y
09.09.2025
Medicamen Bio Standalone June 2025 Net Sales at Rs 38.45 crore, down 7.31% Y-o-Y
11.06.2025
Medicamen Bio Standalone March 2025 Net Sales at Rs 26.00 crore, down 42.24% Y-o-Y